Skip to main content
Caplight Logo









Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc.

Public

Firefly Neuroscience, Inc. is now publicly traded

The data on this page reflects Firefly Neuroscience, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Follow-on Offering

Mar 8, 2026

Total Funding Raised

$2.63M

Company Overview

Firefly Neuroscience, Inc. is based in Kenmore. It has raised $2.63M.

Firefly Neuroscience, Inc. is a medical technology and AI company that provides an FDA-cleared Brain Network Analytics (BNA™) software platform to improve outcomes for patients with mental illnesses and neurological disorders.

AI Layer

Application

Firefly Neuroscience, Inc. Comparables

Compare Firefly Neuroscience, Inc. with similar companies based on industry and business-model similarity.

Firefly Neuroscience, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeuroVigil, Inc.
78%
Mentis Cura
74%
Vistim Labs
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Firefly Neuroscience, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingMar 8, 2026
Private PlacementMar 10, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Amir Geva

Founder, CTO

Founding Team

Dave DeCaprio

President, COO, Board Member

Executive Team

Gil Issachar

Chief Technology Officer

Executive Team

Paul Krzywicki

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withSep 25, 2026

    On Sep 25th '26, Firefly Neuroscience, Inc. and NeuroSigma, Inc. announce a strategic partnership to introduce the Monarch eTNS System to Firefly Neuroscience, Inc.'s nationwide Evoke clinician network and support clinician education.

  • partners_withSep 17, 2026

    On Sep 17th '26 in New York, Firefly Neuroscience, Inc. and Radial Health, Inc. enter a strategic collaboration to pursue integrating AI-powered brain-function measures into diagnostic processes, treatment-pathway identification, care coordination, and outcome tracking.

Book a demo to see all news

For institutional investors. Book with your work email.

Firefly Neuroscience, Inc. Filings

Explore SEC and related filing metadata, where available.

Firefly Neuroscience, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

HeadquartersKenmore
Employee Range25
Year Founded2006
Last FundingMar 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?